Chugai Pharmaceutical Co., Ltd. (CHGCF.PK) on Tuesday reported positive results from its phase I/II TEIEN study evaluating the Port Delivery System with Ranibizumab (PDS) in patients ...

Nokia CorporationStock Exchange Release25 November 2025 at 13:30 EETNokia announces delisting from Paris Stock Exchange Espoo, Finland - Following its announcement on 4 November 2025 regarding the ...

SunPower Inc. (Nasdaq: SPWR) today announced that it received a deficiency notification letter from the Listing Qualifications staff of The Nasdaq Stock ...

Company Completes Final Major Citrus Operations Development Projects Advance Through Entitlement Process with Corkscrew Grove Decision Expected ...

LAVAL, QC, Nov. 24, 2025 /PRNewswire/ - Alimentation Couche-Tard Inc. ("Couche-Tard" or the "Corporation") (TSX: ATD) announces its results for its second quarter ...

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years ...

PennantPark Investment Corporation (NYSE: PNNT) (the "Company") announced today financial results for the fourth quarter and fiscal year ended September 30, 2025.

Maxim Power Corp. ("MAXIM" or the "Corporation") (TSX: MXG) announced today that it has successfully settled a portion of its previously disclosed ...

Lavoro Limited (Nasdaq: LVRO, LVROW) announced today that, as expected, it received a notice of non-compliance (the "Notice") from Nasdaq Stock Market LLC ...

This application is based on the encouraging results from the Phase 3 registration clinical study GLORY-2 (NCT06164873) of mazdutide 9 mg in Chinese adults with moderate to severe obesity. The study ...

Exodus Movement, Inc. (NYSE American: EXOD) ("Exodus" or the "Company"), a leading self-custodial cryptocurrency platform, today announced it has entered ...

Gamehaus Holdings Inc. ("Gamehaus" or the "Company") (Nasdaq: GMHS), a technology-driven mobile game publisher, today announced ...